UBC Medicine receives 40% of national genomics funding
The 10 projects, totaling $101 million, include an effort to reduce the risk of kidney transplant rejection.
By jamming a lock, UBC scientists stop cancer cell growth
A team led by Christopher Ong in Urologic Sciences developed a protein-based drug that stops unrestricted cell proliferation. Next step: A clinical trial.
Potential new diabetes treatment gets tryout in Vancouver
Type 1 diabetes patients are being implanted with packets of pancreatic cells derived from stem cells, with the goal of restoring their insulin production.
An expert in women’s sexual health turns her attention to men
Lori Brotto is comparing two methods for helping men regain sexual health after prostate cancer treatment.
UBC contributes to international hunt for asthma genes
Denise Daley led the Canadian arm of the study, which found five new genes associated with the condition.
A repurposed drug could open door to more stem cell transplants
Peter Zandstra found that etanercept, a drug used to treat arthritis and psoriasis, could boost the survival rate of transplanted blood stem cells.
Older patients and families could pay the price of slowing healthcare spending
Spending on medications, hospitals trending up in B.C., while spending on nursing homes down significantly
A hidden threat of high cholesterol – weakened tendons
A UBC team analyzes the damage that cholesterol inflicts on the Achilles tendon, and looks for ways to improve diagnosis.
A physician’s guide to severe combined immunodeficiency disease
The review, led by UBC’s Stuart Turvey, provides guidance on diagnosis, treatment and family support.
A researcher’s “gut feeling” leads to a reversal on catheter use
Andrei Krassioukov’s efforts led to the withdrawal of a Cochrane review finding that catheters could be reused without an increased risk of infection.